ICON Net Income 2010-2024 | ICLR
ICON annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- ICON net income for the quarter ending December 31, 2024 was $0.260B, a 20.14% increase year-over-year.
- ICON net income for the twelve months ending December 31, 2024 was $0.791B, a 29.26% increase year-over-year.
- ICON annual net income for 2024 was $0.791B, a 29.26% increase from 2023.
- ICON annual net income for 2023 was $0.612B, a 21.18% increase from 2022.
- ICON annual net income for 2022 was $0.505B, a 229.87% increase from 2021.
| ICON Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $791 |
| 2023 | $612 |
| 2022 | $505 |
| 2021 | $153 |
| 2020 | $332 |
| 2019 | $374 |
| 2018 | $323 |
| 2017 | $281 |
| 2016 | $262 |
| 2015 | $240 |
| 2014 | $172 |
| 2013 | $103 |
| 2012 | $55 |
| 2011 | $23 |
| 2010 | $87 |
| 2009 | $94 |
| ICON Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $260 |
| 2024-09-30 | $197 |
| 2024-06-30 | $147 |
| 2024-03-31 | $187 |
| 2023-12-31 | $216 |
| 2023-09-30 | $164 |
| 2023-06-30 | $116 |
| 2023-03-31 | $117 |
| 2022-12-31 | $117 |
| 2022-09-30 | $160 |
| 2022-06-30 | $116 |
| 2022-03-31 | $112 |
| 2021-12-31 | $76 |
| 2021-09-30 | $-94 |
| 2021-06-30 | $74 |
| 2021-03-31 | $97 |
| 2020-12-31 | $101 |
| 2020-09-30 | $92 |
| 2020-06-30 | $48 |
| 2020-03-31 | $92 |
| 2019-12-31 | $99 |
| 2019-09-30 | $95 |
| 2019-06-30 | $92 |
| 2019-03-31 | $88 |
| 2018-12-31 | $88 |
| 2018-09-30 | $85 |
| 2018-06-30 | $72 |
| 2018-03-31 | $78 |
| 2017-12-31 | $71 |
| 2017-09-30 | $74 |
| 2017-06-30 | $65 |
| 2017-03-31 | $71 |
| 2016-12-31 | $74 |
| 2016-09-30 | $64 |
| 2016-06-30 | $61 |
| 2016-03-31 | $63 |
| 2015-12-31 | $64 |
| 2015-09-30 | $62 |
| 2015-06-30 | $59 |
| 2015-03-31 | $56 |
| 2014-12-31 | $54 |
| 2014-09-30 | $50 |
| 2014-06-30 | $41 |
| 2014-03-31 | $36 |
| 2013-12-31 | $33 |
| 2013-09-30 | $28 |
| 2013-06-30 | $22 |
| 2013-03-31 | $19 |
| 2012-12-31 | $21 |
| 2012-09-30 | $18 |
| 2012-06-30 | $13 |
| 2012-03-31 | $9 |
| 2011-12-31 | $4 |
| 2011-09-30 | $-3 |
| 2011-06-30 | $13 |
| 2011-03-31 | $8 |
| 2010-12-31 | $22 |
| 2010-09-30 | $20 |
| 2010-06-30 | $23 |
| 2010-03-31 | $22 |
| 2009-12-31 | $31 |
| 2009-09-30 | $24 |
| 2009-06-30 | $19 |
| 2009-03-31 | $21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.132B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.516B | 27.37 |
| Elevance Health (ELV) | United States | $98.469B | 13.19 |
| CVS Health (CVS) | United States | $85.419B | 12.50 |
| Cencora (COR) | United States | $53.926B | 19.57 |
| DiDi Global (DIDIY) | China | $23.525B | 0.00 |
| Natera (NTRA) | United States | $19.117B | 0.00 |
| BioMerieux (BMXMF) | France | $14.914B | 0.00 |
| Solventum (SOLV) | United States | $13.154B | 12.27 |
| Revvity (RVTY) | United States | $12.712B | 21.59 |
| Avantor (AVTR) | United States | $11.045B | 16.21 |
| CochLear (CHEOY) | Australia | $10.877B | 0.00 |
| Doximity (DOCS) | United States | $10.834B | 56.34 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.609B | 0.00 |
| Viatris (VTRS) | United States | $10.397B | 3.29 |
| Medpace Holdings (MEDP) | United States | $9.283B | 24.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.768B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.697B | 14.59 |
| HealthEquity (HQY) | United States | $7.644B | 37.60 |
| Bausch + Lomb (BLCO) | Canada | $5.111B | 23.39 |
| Amplifon S.p.A (AMFPF) | Italy | $4.961B | 26.19 |
| Organon (OGN) | United States | $3.841B | 3.91 |
| Alignment Healthcare (ALHC) | United States | $3.572B | 0.00 |
| Sotera Health (SHC) | United States | $3.305B | 19.11 |
| BrightSpring Health Services (BTSG) | United States | $3.165B | 32.89 |
| Surgery Partners (SGRY) | United States | $3.031B | 34.93 |
| Concentras Parent (CON) | United States | $2.781B | 14.47 |
| GeneDx Holdings (WGS) | United States | $2.486B | 295.22 |
| Ardent Health Partners (ARDT) | United States | $1.963B | 0.00 |
| Progyny (PGNY) | United States | $1.908B | 42.15 |
| Agilon Health (AGL) | United States | $1.785B | 0.00 |
| Premier (PINC) | United States | $1.760B | 11.27 |
| PACS (PACS) | United States | $1.713B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.692B | 36.75 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.243B | 10.42 |
| Establishment Labs Holdings (ESTA) | $1.177B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.031B | 0.00 |
| CareDx (CDNA) | United States | $0.984B | 16.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.934B | 7.39 |
| Embecta (EMBC) | United States | $0.741B | 5.08 |
| QDM (QDMI) | Hong Kong, SAR China | $0.526B | 13.77 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 13.94 |
| Enhabit (EHAB) | United States | $0.444B | 41.86 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.269B | 11.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.265B | 0.00 |
| Nutex Health (NUTX) | United States | $0.256B | 5.10 |
| LifeMD (LFMD) | United States | $0.243B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.168B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| So-Young (SY) | China | $0.098B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.056B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 6.57 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |